SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-047900
Filing Date
2015-05-29
Accepted
2015-05-29 15:30:28
Documents
2
Period of Report
2015-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2217
2 POA DOCUMENT poa.txt EX-24.3_586170 4112
  Complete submission text file 0001209191-15-047900.txt   7809
Mailing Address C/O CERULEAN PHARMA INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
BELOFF GREGG (Reporting) CIK: 0001171002 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 15899185

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations